% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Delacher:128318,
author = {M. Delacher$^*$ and C. D. Imbusch$^*$ and D. Weichenhan$^*$
and A. Breiling$^*$ and A. Hotz-Wagenblatt$^*$ and U.
Träger$^*$ and A.-C. Hofer$^*$ and D. Kägebein$^*$ and Q.
Wang$^*$ and F. Frauhammer$^*$ and J.-P. Mallm$^*$ and K.
Bauer$^*$ and C. Herrmann$^*$ and P. A. Lang and B.
Brors$^*$ and C. Plass$^*$ and M. Feuerer$^*$},
title = {{G}enome-wide {DNA}-methylation landscape defines
specialization of regulatory {T} cells in tissues.},
journal = {Nature immunology},
volume = {18},
number = {10},
issn = {1529-2916},
address = {New York, NY},
publisher = {Nature America Inc.},
reportid = {DKFZ-2017-04335},
pages = {1160 - 1172},
year = {2017},
abstract = {Regulatory T cells (Treg cells) perform two distinct
functions: they maintain self-tolerance, and they support
organ homeostasis by differentiating into specialized tissue
Treg cells. We found that epigenetic modifications defined
the molecular characteristics of tissue Treg cells.
Tagmentation-based whole-genome bisulfite sequencing
revealed more than 11,000 regions that were methylated
differentially in pairwise comparisons of tissue Treg cell
populations and lymphoid T cells. Similarities in the
epigenetic landscape led to the identification of a common
tissue Treg cell population that was present in many organs
and was characterized by gain and loss of DNA methylation
that included many gene sites associated with the TH2 subset
of helper T cells, such as the gene encoding cytokine IL-33
receptor ST2, as well as the production of
tissue-regenerative factors. Furthermore, the ST2-expressing
population was dependent on the transcriptional regulator
BATF and could be expanded by IL-33. Thus, tissue Treg cells
integrate multiple waves of epigenetic reprogramming that
define their tissue-restricted specialization.},
keywords = {Biomarkers (NLM Chemicals)},
cin = {D100 / C010 / W180 / G200 / B066 / B080 / L101},
ddc = {610},
cid = {I:(DE-He78)D100-20160331 / I:(DE-He78)C010-20160331 /
I:(DE-He78)W180-20160331 / I:(DE-He78)G200-20160331 /
I:(DE-He78)B066-20160331 / I:(DE-He78)B080-20160331 /
I:(DE-He78)L101-20160331},
pnm = {314 - Tumor immunology (POF3-314)},
pid = {G:(DE-HGF)POF3-314},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:28783152},
doi = {10.1038/ni.3799},
url = {https://inrepo02.dkfz.de/record/128318},
}